Announcements
- OrthoPediatrics Corp. Continued Leading Sponsorship at 2024 EPOSNA Annual Meeting
- OrthoPediatrics Corp. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
- OrthoPediatrics Corp. Receives “Breakthrough Device” Designation from FDA for eLLi™ Growing Rod System for Pediatric Patients with Scoliosis
- OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024
- OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)
- OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results
- OrthoPediatrics Corp. Launches New RESPONSE Rib and Pelvic Fixation System for EOS Scoliosis
- OrthoPediatrics Corp. Named One of the 2024 Best Places to Work in Indiana
- OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024
More ▼
Key statistics
As of last trade OrthoPediatrics Corp (2X7:DEU) traded at 30.60, -4.97% below its 52-week high of 32.20, set on May 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 29.80 |
---|---|
High | 30.60 |
Low | 29.80 |
Bid | 31.00 |
Offer | 31.20 |
Previous close | 29.80 |
Average volume | 13.90 |
---|---|
Shares outstanding | 23.83m |
Free float | 16.24m |
P/E (TTM) | -- |
Market cap | 806.13m USD |
EPS (TTM) | -0.9647 USD |
Data delayed at least 15 minutes, as of May 28 2024.
More ▼